Xencor, Inc.
Engineered IL-2 Fc fusion proteins
Last updated:
Abstract:
The present invention provides IL-2-Fc fusion proteins comprising IL-2 variants.
Status:
Grant
Type:
Utility
Filling date:
30 Nov 2018
Issue date:
3 May 2022